• Details for 2015 Next-Generation Pharmacist<sup>TM</sup> Awards Gala
  • Bringing Pharmacy to the Next Level
  • New Insulin Pen Strength Gets FDA Nod
  • The Future of Pharmacy
  • Pharmacy Students Provide Care to Farm Workers
  • Top Traits of Highly Effective Hospital Pharmacy Technicians
  • Insulin Pens: Improving Adherence and Reducing Costs

Latest News

Psoriasis Drug Development Pact Dissolved Due to Suicide Concerns
Krystle Vermes
Amgen has terminated its co-development and commercialization of brodalumab with AstraZeneca after observing suicidal ideation and behavior in clinical trial participants.
Jeannette Y. Wick, RPh, MBA, FASCP
Light or moderate alcohol intake has been associated with health benefits such as reduced risk of cardiovascular events, but these benefits disappear as intake increases.
Ryan Marotta, Assistant Editor
The FDA today approved a new 200 unit/mL formulation of Lilly’s Humalog KwikPen for patients with type 1 and type 2 diabetes.
Allison Gilchrist, Associate Editor
Noting national drug shortages often disproportionately affect pediatric patients, the Pediatric Pharmacy Advocacy Group (PPAG) is encouraging the FDA to include child-specific considerations in its policies for preventing and mitigating drug shortages.
Meghan Ross, Associate Editor
Hospitals serving large populations of non-native English speakers perform worse on patient satisfaction scores that are tied to reimbursement from the US Centers for Medicare and Medicaid Services.
Meghan Ross, Associate Editor
The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.
Krystle Vermes
The FDA had accepted for review Tris Pharma’s New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
Allison Gilchrist, Associate Editor
Electronic prescribing technology is permitting pharmacists to focus less on administrative tasks and more on providing direct patient care.
Ryan Marotta, Assistant Editor
Although previous reports focused on the risks of antidepressant use in new mothers, a recent study stressed the benefits these drugs provide for women with postpartum depression.

Trending Now

$AD300x250BB$
Previous TabNext Tab
Strategic Alliance Partners
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$